Press Releases

Feb 12, 2018

Summary Toggle SMRT Sequencing of Human Genomes to be Showcased at AGBT Conference

Presentations will highlight importance of SMRT Sequencing for rare diseases, structural variation, and more

SMRT Sequencing of Human Genomes to be Showcased at AGBT Conference 26.7 KB
Feb 8, 2018

Summary Toggle Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif. , Feb. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the "ITC") has terminated its investigation into whether Oxford Nanopore's MinION and PromethION devices and associated

Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore 20.8 KB
Feb 1, 2018

Summary Toggle Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results

Annual Product and Service Revenue Increases 19% Year over Year

Pacific Biosciences Announces Fourth Quarter and Annual 2017 Financial Results 31.8 KB
Jan 25, 2018

Summary Toggle BGI Increases Long-Read Sequencing Capacity with Purchase of 10 PacBio Sequel Systems

MENLO PARK, California and SHENZHEN, China , Jan. 25, 2018 (GLOBE NEWSWIRE) -- BGI, one of the world's largest genomics organizations, and Pacific Biosciences of California, Inc. (Nasdaq: PACB), the leader in long-read sequencing, today announced an agreement by BGI Genomics to purchase an

BGI Increases Long-Read Sequencing Capacity with Purchase of 10 PacBio Sequel Systems 23 KB
Jan 22, 2018

Summary Toggle Pacific Biosciences of California, Inc. Fourth Quarter and Year-End 2017 Financial Results Call

MENLO PARK, Calif. , Jan. 22, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Fourth Quarter and Year-End 2017 Financial Results on Thursday, February 1, 2018 , at 4:30pm Eastern Time .

Pacific Biosciences of California, Inc. Fourth Quarter and Year-End 2017 Financial Results Call 18.4 KB
Nov 2, 2017

Summary Toggle Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer

MENLO PARK, Calif. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and

Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer 16.7 KB
Nov 2, 2017

Summary Toggle Pacific Biosciences of California, Inc. Announces Third Quarter 2017 Financial Results

Product and Service Revenue Increases by 9% Over Same Period in Previous Year

Pacific Biosciences of California, Inc. Announces Third Quarter 2017 Financial Results 16.7 KB
Oct 20, 2017

Summary Toggle Pacific Biosciences of California, Inc. Third Quarter 2017 Financial Results Call

MENLO PARK, Calif. , Oct. 20, 2017 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Third Quarter 2017 Financial Results on Thursday, November 2, 2017 , at 4:30pm Eastern Time .

Pacific Biosciences of California, Inc. Third Quarter 2017 Financial Results Call 18.3 KB
Oct 16, 2017

Summary Toggle Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes

PacBio Sequencing Reveals More Functionally Important Variants; Complete Solution for Structural Variant Detection to be Featured at ASHG Annual Meeting

Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes 90.1 KB
Oct 3, 2017

Summary Toggle Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting

More than 30 presentations demonstrate utility of SMRT Sequencing for human biomedical applications

Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting 31.3 KB

:
Price
Last Trade
Change
Change (%)
Volume
52 Week High
52 Week Low
Day High
Day Low

Press Releases

Press Releases

STOCK QUOTE

Investor
Contact

Investor Relations

Press Releases

STOCK QUOTE

Investor Contact

Investor
Contact